MedTrace Logo

VircapSeq Virus Detection in Sézary Syndrome

NCT02836886 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2024-05-28

Study results available
· View outcomes & findings →

Summary

This study will be using this technique, called "VirCapSeq-VERT" to analyze the white blood cells of patients with Sézary syndrome. This could provide the foundation for future studies looking to understand the role that viruses play in the origin of Sézary syndrome. This could have important implications for the future development of new and effective therapies for the disease.

Conditions

  • Lymphoma, T-Cell, Cutaneous
  • Sézary Syndrome

Sponsors & Collaborators

Principal Investigators

  • Larisa G Geskin, MD · Columbia University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02836886 on ClinicalTrials.gov